FOLD
Price
$14.29
Change
+$0.01 (+0.07%)
Updated
Feb 5, 02:54 PM (EDT)
Capitalization
4.48B
14 days until earnings call
Intraday BUY SELL Signals
GPCR
Price
$74.58
Change
-$6.68 (-8.22%)
Updated
Feb 5, 03:01 PM (EDT)
Capitalization
5.74B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FOLD vs GPCR

Header iconFOLD vs GPCR Comparison
Open Charts FOLD vs GPCRBanner chart's image
Amicus Therapeutics
Price$14.29
Change+$0.01 (+0.07%)
Volume$7.43K
Capitalization4.48B
Structure Therapeutics
Price$74.58
Change-$6.68 (-8.22%)
Volume$200
Capitalization5.74B
FOLD vs GPCR Comparison Chart in %
View a ticker or compare two or three
VS
FOLD vs. GPCR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (FOLD: $14.27 vs. GPCR: $81.26)
Brand notoriety: FOLD and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 71% vs. GPCR: 59%
Market capitalization -- FOLD: $4.48B vs. GPCR: $5.74B
FOLD [@Biotechnology] is valued at $4.48B. GPCR’s [@Biotechnology] market capitalization is $5.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 0 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 0 green, 5 red.
According to our system of comparison, GPCR is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 3 TA indicator(s) are bullish while GPCR’s TA Score has 4 bullish TA indicator(s).

  • FOLD’s TA Score: 3 bullish, 4 bearish.
  • GPCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than FOLD.

Price Growth

FOLD (@Biotechnology) experienced а -0.07% price change this week, while GPCR (@Biotechnology) price change was -8.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

FOLD is expected to report earnings on Feb 19, 2026.

GPCR is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.74B) has a higher market cap than FOLD($4.48B). GPCR YTD gains are higher at: 16.837 vs. FOLD (0.211). FOLD has higher annual earnings (EBITDA): 59.3M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. FOLD (264M). GPCR has less debt than FOLD: GPCR (7.09M) vs FOLD (443M). FOLD has higher revenues than GPCR: FOLD (599M) vs GPCR (0).
FOLDGPCRFOLD / GPCR
Capitalization4.48B5.74B78%
EBITDA59.3M-246.42M-24%
Gain YTD0.21116.8371%
P/E RatioN/AN/A-
Revenue599M0-
Total Cash264M799M33%
Total Debt443M7.09M6,248%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDGPCR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 23 days ago
71%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
FOLD
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPNNX6.220.05
+0.77%
Invesco SteelPath MLP Income R
TEMIX33.690.20
+0.60%
Franklin Mutual International Value A
ZGFIX18.87-0.07
-0.37%
American Beacon Ninety One Gbl Frnchs R5
REEBX62.13-0.37
-0.59%
American Funds EUPAC R2E
MELIX17.43-0.28
-1.58%
Morgan Stanley Inst EMkts Ldrs I

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been closely correlated with ACET. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if FOLD jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.07%
ACET - FOLD
80%
Closely correlated
-3.51%
GPCR - FOLD
76%
Closely correlated
-3.01%
PHGE - FOLD
75%
Closely correlated
-7.36%
INBX - FOLD
74%
Closely correlated
-2.96%
PMN - FOLD
73%
Closely correlated
-1.57%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with ATOS. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-3.01%
ATOS - GPCR
80%
Closely correlated
-4.34%
PHGE - GPCR
77%
Closely correlated
-7.36%
PMN - GPCR
77%
Closely correlated
-1.57%
CANF - GPCR
74%
Closely correlated
-0.25%
ANL - GPCR
73%
Closely correlated
+7.23%
More